NAMI Advocacy Actions

Letter to Senate HELP Committee leadership in response to the request for information (RFI) on the health care workforce shortage.

Letter to Members of Congress in opposition to S.184 and H.R. 277 - the Regulations from the Executive in Need of Scrutiny Act of 2023 (REINS Act).

Regulatory comments to HHS Secretary Becerra and CMS Administrator Brooks-LaSure in response to the Advancing Interoperability and Improving Prior Authorization Proposed Rule.

Regulatory comment to CMS Administrator Brooks-Lasure in response to the proposed rule, "“Advancing Interoperability and Improving Prior Authorization Processes."

Statement in support of federal and state policies that ensure those who remain eligible for Medicaid and CHIP understand this process and successfully reenroll, while those who are no longer eligible transition to other forms of quality, affordable healthcare coverage.

Statement urging Congress to support and protect Medicaid.

Letter to Medicare Director Seshamani on Advance Notice of Methodological Changes for Calendar Year (CY) 2024 for Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies.

Letter to Representatives Napolitano and Stewart for co-chairing the bipartisan Congressional Mental Health Caucus in the 118th session.

Regulatory comments to HHS Secretary Becerra on New Mexico's Medicaid 1115 waiver renewal.

Regulatory comment to HHS Secretary Becerra, OCR Director Rainer, and SAMHSA Assistant Secretary Delphin-Rittmon on the Notice of Proposed Rule Making (NPRM or proposed rule) to 42 CFR Part 2.